Cardiothoracic Surgeons are medical experts who perform surgeries on the heart, lungs, and other organs in the chest. They treat conditions like coronary artery disease, heart valve issues, lung cancer, and congenital defects. These surgeons are skilled in complex procedures such as coronary artery bypass grafting (CABG), heart valve repairs, lung resections, and heart transplants. Their expertise is vital in treating serious and often life-threatening conditions. With their extensive knowledge of both cardiovascular and respiratory systems, they perform delicate surgeries that can significantly improve heart and lung function, saving lives in critical situations. Their ability to handle high-risk surgeries is essential for successful patient outcomes.
Beyond surgery, cardiothoracic surgeons are involved in patient care at every stage. They assess patients before surgery, develop personalized treatment plans, and guide them through the entire process. Post-surgery, they monitor recovery, manage complications, and assist with rehabilitation. These surgeons work closely with other healthcare professionals, including cardiologists and pulmonologists, to ensure comprehensive treatment. Their role is crucial not only in addressing immediate surgical needs but also in supporting long-term health improvements. Through their expertise and collaborative efforts, cardiothoracic surgeons significantly contribute to enhancing the quality of life for patients with severe heart and lung conditions. Their ongoing commitment to research ensures that they remain at the forefront of surgical innovation.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India